Age and gender differences in non-motor symptoms in people with Parkinson’s disease

Background Non-motor symptoms of Parkinson’s disease (PD) are highly prevalent and heterogenic. Previous studies aimed to gain more insight on this heterogeneity by investigating age and gender differences in non-motor symptom severity, but findings were inconsistent. Furthermore, besides examining the single effects of age and gender, the interaction between them in relation to non-motor functioning has -as far as we know- not been investigated before. Objectives To investigate the association of age and gender identity -as well as the interaction between age and gender identity- with non-motor symptoms and their impact on quality of life. Methods We combined three large and independent studies. This approach resulted in a total number of unique participants of 1,509. We used linear regression models to assess the association of age and gender identity, and their interaction, with non-motor symptoms and their impact on quality of life. Results Older people with PD generally had worse cognitive functioning, worse autonomic functioning and worse quality of life. Women with PD generally experienced more anxiety, worse autonomic functioning and worse quality of life compared to men with PD, whereas men with PD generally had worse cognitive functioning. In interaction analyses by age and gender identity, depressive symptoms and anxiety were disproportionally worse with increasing age in women compared to men. Conclusion Our findings indicate that both age and gender -as well as their interaction- are differentially associated with non-motor symptoms of PD. Both research and clinical practice should pay more attention to demographic subgroups differences and possible different treatment approaches with respect to age and gender. We showed how combining datasets is of added value in this kind of analyses and encourage others to use similar approaches.

[1]  Madeleine. E. Hackney,et al.  Gender differences in motor and non-motor symptoms in individuals with mild-moderate Parkinson’s disease , 2023, PloS one.

[2]  R. Helmich,et al.  Time trends in demographic characteristics of participants and outcome measures in Parkinson’s disease research: A 19-year single-center experience , 2023, Clinical parkinsonism & related disorders.

[3]  S. Oertelt-Prigione,et al.  The impact of multiple gender dimensions on health-related quality of life in persons with Parkinson’s disease: an exploratory study , 2022, Journal of Neurology.

[4]  M. Nalls,et al.  Longitudinal risk factors for developing depressive symptoms in Parkinson's disease , 2021, Journal of the Neurological Sciences.

[5]  B. Bloem,et al.  Rationale and design to evaluate the PRIME Parkinson care model: a prospective observational evaluation of proactive, integrated and patient-centred Parkinson care in The Netherlands (PRIME-NL) , 2021, BMC Neurology.

[6]  B. Bloem,et al.  Better quality of life and less caregiver strain in young-onset Parkinson’s disease: a multicentre retrospective cohort study , 2020, Journal of Neurology.

[7]  B. Bloem,et al.  Personalized Care Management for Persons with Parkinson’s Disease , 2020, Journal of Parkinson's disease.

[8]  B. Post,et al.  Young Onset Parkinson’s Disease: A Modern and Tailored Approach , 2020, Journal of Parkinson's disease.

[9]  S. Lupien,et al.  Gender roles in relation to symptoms of anxiety and depression among students and workers , 2020, Anxiety, stress, and coping.

[10]  K. Matthews,et al.  The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN) , 2019, Menopause.

[11]  R. C. Helmich,et al.  The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease , 2019, BMC Neurology.

[12]  F. Blandini,et al.  Parkinson’s Disease in Women and Men: What’s the Difference? , 2019, Journal of Parkinson's disease.

[13]  B. Bloem,et al.  The cost-effectiveness of specialized nursing interventions for people with Parkinson’s disease: the NICE-PD study protocol for a randomized controlled clinical trial , 2019, Trials.

[14]  D. Aarsland,et al.  Risk factors for non-motor symptoms in Parkinson's disease , 2018, The Lancet Neurology.

[15]  Eyal Oren,et al.  Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, The Lancet. Neurology.

[16]  K. Marder,et al.  Sex differences in LRRK2 G2019S and idiopathic Parkinson's Disease , 2017, Annals of clinical and translational neurology.

[17]  Ji Sun Kim,et al.  Gender Differences of Nonmotor Symptoms Affecting Quality of Life in Parkinson Disease , 2017, Neurodegenerative Diseases.

[18]  K. Hamberg,et al.  Gender differences in Parkinson's disease: A clinical perspective , 2017, Acta neurologica Scandinavica.

[19]  S. Tomic,et al.  Impact of autonomic dysfunctions on the quality of life in Parkinson’s disease patients , 2017, Acta Neurologica Belgica.

[20]  R. Marconi,et al.  Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk? , 2017, Parkinsonism & related disorders.

[21]  M. Kovács,et al.  Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson's Disease , 2016, Parkinson's disease.

[22]  A. Tröster,et al.  Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease , 2015, Neurology.

[23]  K. Nie,et al.  Sex differences in cognition among Chinese people with Parkinson’s disease , 2015, Journal of Clinical Neuroscience.

[24]  P. Chan,et al.  Gender differences on motor and non-motor symptoms of de novo patients with early Parkinson’s disease , 2014, Neurological Sciences.

[25]  Bastiaan R Bloem,et al.  Revolutionising management of chronic disease: the ParkinsonNet approach , 2014, BMJ : British Medical Journal.

[26]  M. T. Pellecchia,et al.  Gender differences in non-motor symptoms in early, drug naïve Parkinson’s disease , 2013, Journal of Neurology.

[27]  Wei Song,et al.  Disease duration-related differences in non-motor symptoms: A study of 616 Chinese Parkinson's disease patients , 2013, Journal of the Neurological Sciences.

[28]  F. Marrosu,et al.  Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease , 2012, Journal of the Neurological Sciences.

[29]  D. Aarsland,et al.  Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease , 2012, Journal of Neurology.

[30]  I. Tendolkar,et al.  Prevalence of depression in Parkinson's disease: Effects of disease stage, motor subtype and gender , 2011, Journal of the Neurological Sciences.

[31]  A. Kishore,et al.  Do nonmotor symptoms in Parkinson's disease differ from normal aging? , 2011, Movement disorders : official journal of the Movement Disorder Society.

[32]  H. Kaciuba-uścilko,et al.  Gender differences in thermoregulation , 2001, Current opinion in clinical nutrition and metabolic care.

[33]  L. M. Franks,et al.  Points: Medical research , 1988 .

[34]  Y. Ben-Shlomo,et al.  The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. , 2014, Parkinsonism & Related Disorders.

[35]  P. Martínez-Martín,et al.  The Burden of Non-Motor Symptoms , 2011 .